search
Back to results

PREhospital Routage of Acute STroke Patients With Suspected Large Vessel Occlusion: Mothership Versus Drip and Ship (PRESTO-F)

Primary Purpose

Stroke

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
mothership
Sponsored by
University Hospital, Caen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Stroke focused on measuring thrombectomy, drip'n'ship versus mothership, cost/effectiveness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • A call to the emergency medical assistance service;
  • age> 18y,
  • known time of stroke onset;
  • transportation time from scene to the CSC longer than time to go to the nearest stroke unit or telemedicine hub;
  • transportation time from scene to the CSC compatible with IV thrombolysis;
  • known time from onset, RACE score ≥5.

Exclusion Criteria:

  • transportation time from scene to the CSC longer than time to go to the nearest stroke unit or telemedicine hub.
  • no ambulance available
  • bedridden patient

Sites / Locations

  • University hospital of CaenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Mothership

drip'n'ship

Arm Description

Acute stroke patients with suspected large vessel occlusion will be directly transferred to the nearest transportation to the endovascular center

Acute stroke patients with suspected large vessel occlusion will be transferred to the closest local stroke centre or telemedicine hub as done with the current stroke protocol

Outcomes

Primary Outcome Measures

Incremental cost-utility ratio
Incremental cost-utility ratio (ICUR) at 12 months, defined as the ratio of the incremental cost of management by transfer to a CSC with MT (compared to the control arm "local PSC") to the gain in healthy survival (quality adjusted life years, QALYs).

Secondary Outcome Measures

modified Rankin scale score
is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6, running from perfect health without symptoms to death. Modified Rankin Scale score will be evaluated through a structured telephone-based interview performed by a central assessor who is blinded to group assignment

Full Information

First Posted
October 2, 2019
Last Updated
April 9, 2021
Sponsor
University Hospital, Caen
search

1. Study Identification

Unique Protocol Identification Number
NCT04121013
Brief Title
PREhospital Routage of Acute STroke Patients With Suspected Large Vessel Occlusion: Mothership Versus Drip and Ship
Acronym
PRESTO-F
Official Title
PREhospital Routage of Acute STroke Patients With Suspected Large Vessel Occlusion: Mothership Versus Drip and Ship, a Randomized Control Study in France (PRESTO-F)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 30, 2021 (Actual)
Primary Completion Date
January 2022 (Anticipated)
Study Completion Date
January 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background: The outcome of ischemic stroke is related to the brain lesion volume and this volume of infarction is directly related to the time to reperfusion, which therefore depends on the time to initiation of therapy. Acute ischemic stroke is treated medically with the administration of intravenous rtPA, but recent randomized controlled trials have shown the efficacy of mechanical thrombectomy and is now the new gold standard in ischemic stroke. This new therapeutic strategy has created two possibilities for pre-hospital decision-making: i/ transport the patient directly to the nearest stroke unit to receive alteplase and then if indicated perform a thrombectomy (drip and ship) or ii/ bypassing thrombolysis centres in favour of endovascular thrombectomy (mothership). Objective: To compare cost/effectiveness of transfer to the closest local stroke centre or telemedicine hub to direct transfer to the comprehensive stroke cent(CSC) in patients acute stroke with suspected large vessel occlusion. Medical and economic expected impact: We hypothesize that direct transportation to CSC is associated with better clinical outcome in case of acute ischaemic stroke due to intracranial large vessel occlusion. However, we have to demonstrate that this approach is not associated with time from onset harm in patients not eligible to mechanical thrombectomy.
Detailed Description
Design: Multicenter, two-arm, prospective, open, blinded end-point (PROBE), randomized, clinical trial Primary endpoint: Incremental cost-utility ratio at 12 months. Secondary endpoints: modified Rankin scale and EuroQoL5D scale at 3 months. Eligibility criteria: A call to the emergency medical assistance service, 18 years and older, severe acute stroke symptoms, transportation time from scene to the CSC longer than time to go to the nearest stroke unit or telemedicine hub, transportation time from scene to the CSC compatible with IV thrombolysis, known time from onset, RACE score (assessed by medical emergency technicians) ≥5. Experimental arm: direct transportation to the CSC. Control arm: transfer to the closest local stroke centre or telemedicine hub. Sample size: 800 patients, 400 for each arm.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
thrombectomy, drip'n'ship versus mothership, cost/effectiveness

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
800 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mothership
Arm Type
Active Comparator
Arm Description
Acute stroke patients with suspected large vessel occlusion will be directly transferred to the nearest transportation to the endovascular center
Arm Title
drip'n'ship
Arm Type
No Intervention
Arm Description
Acute stroke patients with suspected large vessel occlusion will be transferred to the closest local stroke centre or telemedicine hub as done with the current stroke protocol
Intervention Type
Other
Intervention Name(s)
mothership
Intervention Description
Randomized controlled study: allocation to active or no intervention arm will be done accordingly to the design temporal sequence
Primary Outcome Measure Information:
Title
Incremental cost-utility ratio
Description
Incremental cost-utility ratio (ICUR) at 12 months, defined as the ratio of the incremental cost of management by transfer to a CSC with MT (compared to the control arm "local PSC") to the gain in healthy survival (quality adjusted life years, QALYs).
Time Frame
12 months
Secondary Outcome Measure Information:
Title
modified Rankin scale score
Description
is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. The scale runs from 0-6, running from perfect health without symptoms to death. Modified Rankin Scale score will be evaluated through a structured telephone-based interview performed by a central assessor who is blinded to group assignment
Time Frame
90 days
Other Pre-specified Outcome Measures:
Title
EuroQoL5D scale
Description
EQ-5D is a standardized instrument for measuring generic health status. In the description part, health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. EuroQol5D scale will be evaluated through a structured telephone-based interview performed by a central assessor who is blinded to group assignment
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A call to the emergency medical assistance service; age> 18y, known time of stroke onset; transportation time from scene to the CSC longer than time to go to the nearest stroke unit or telemedicine hub; transportation time from scene to the CSC compatible with IV thrombolysis; known time from onset, RACE score ≥5. Exclusion Criteria: transportation time from scene to the CSC longer than time to go to the nearest stroke unit or telemedicine hub. no ambulance available bedridden patient
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Richard Macrez, Dr
Phone
0231470213
Email
macrez@cyceron.fr
First Name & Middle Initial & Last Name or Official Title & Degree
emmanuel touze, Pr
Email
emmanuel.touze@unicaen.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emmanuel Touze, Pr
Organizational Affiliation
University hospital of Caen
Official's Role
Principal Investigator
Facility Information:
Facility Name
University hospital of Caen
City
Caen
State/Province
Normanide
ZIP/Postal Code
14000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Richard Macrez, Dr
Phone
0231470213
Email
macrez@cyceron.fr
First Name & Middle Initial & Last Name & Degree
Emmanuel Touze, Pr
Email
emmanuel.touze@unicaen.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

PREhospital Routage of Acute STroke Patients With Suspected Large Vessel Occlusion: Mothership Versus Drip and Ship

We'll reach out to this number within 24 hrs